The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Injectable IVF Medications Market Research Report 2025
Synopsis
Injectable IVF (In Vitro Fertilization) medications are pharmaceutical drugs administered via injection to stimulate and regulate a woman's reproductive system during the fertility treatment process. These medications typically include hormones such as gonadotropins and follicle-stimulating hormone (FSH), which encourage the development of multiple eggs within the ovaries. Additionally, other drugs like human chorionic gonadotropin (hCG) are used to trigger the final maturation of eggs before retrieval. Injectable IVF medications play a crucial role in controlling the ovulation process, optimizing egg production, and enhancing the chances of successful fertilization during assisted reproductive technologies.
The global Injectable IVF Medications market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The fertility preservation and infertility treatment market has witnessed significant growth in recent years, driven by factors such as increasing infertility rates, delayed pregnancies, advancements in assisted reproductive technologies (ART), and growing awareness. Fertility preservation technologies, including egg freezing and sperm banking, have gained popularity among individuals seeking to preserve their reproductive potential. In the infertility treatment segment, in vitro fertilization (IVF), intrauterine insemination (IUI), and other ART procedures have become mainstream options. Future developments are anticipated in areas such as personalized medicine, gene editing technologies, and improved success rates in ART procedures. The market is likely to see ongoing advancements, innovations, and collaborations aimed at addressing infertility challenges and expanding the range of options available to individuals and couples.
This report aims to provide a comprehensive presentation of the global market for Injectable IVF Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable IVF Medications.
Report Scope
The Injectable IVF Medications market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injectable IVF Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable IVF Medications manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gonal-F (Merck)
Follistim (Organon)
Bravelle (Ferring)
Menopur (Ferring)
Fostimon (IBSA)
Puregon (Organon)
BEMFOLA (Gedeon Richter)
Novarel (Ferring)
Ovidrel (Merck)
Synarel (Pfizer Medical)
Follitrope (LG Chem)
Profasi (Serum Institute Of India)
Livzon
GenSci
Segment by Type
Follicle Stimulating Hormone (FSH)
Luteinizing Hormone (LH)
Human Chorionic Gonadotropin (hCG)
Others
Segment by Application
IVF and Embryo Transfer
Infertility Treatment
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Injectable IVF Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Injectable IVF Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Injectable IVF (In Vitro Fertilization) medications are pharmaceutical drugs administered via injection to stimulate and regulate a woman's reproductive system during the fertility treatment process. These medications typically include hormones such as gonadotropins and follicle-stimulating hormone (FSH), which encourage the development of multiple eggs within the ovaries. Additionally, other drugs like human chorionic gonadotropin (hCG) are used to trigger the final maturation of eggs before retrieval. Injectable IVF medications play a crucial role in controlling the ovulation process, optimizing egg production, and enhancing the chances of successful fertilization during assisted reproductive technologies.
The global Injectable IVF Medications market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The fertility preservation and infertility treatment market has witnessed significant growth in recent years, driven by factors such as increasing infertility rates, delayed pregnancies, advancements in assisted reproductive technologies (ART), and growing awareness. Fertility preservation technologies, including egg freezing and sperm banking, have gained popularity among individuals seeking to preserve their reproductive potential. In the infertility treatment segment, in vitro fertilization (IVF), intrauterine insemination (IUI), and other ART procedures have become mainstream options. Future developments are anticipated in areas such as personalized medicine, gene editing technologies, and improved success rates in ART procedures. The market is likely to see ongoing advancements, innovations, and collaborations aimed at addressing infertility challenges and expanding the range of options available to individuals and couples.
This report aims to provide a comprehensive presentation of the global market for Injectable IVF Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable IVF Medications.
Report Scope
The Injectable IVF Medications market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injectable IVF Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable IVF Medications manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gonal-F (Merck)
Follistim (Organon)
Bravelle (Ferring)
Menopur (Ferring)
Fostimon (IBSA)
Puregon (Organon)
BEMFOLA (Gedeon Richter)
Novarel (Ferring)
Ovidrel (Merck)
Synarel (Pfizer Medical)
Follitrope (LG Chem)
Profasi (Serum Institute Of India)
Livzon
GenSci
Segment by Type
Follicle Stimulating Hormone (FSH)
Luteinizing Hormone (LH)
Human Chorionic Gonadotropin (hCG)
Others
Segment by Application
IVF and Embryo Transfer
Infertility Treatment
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Injectable IVF Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Injectable IVF Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Injectable IVF Medications Market Overview
1.1 Product Overview and Scope of Injectable IVF Medications
1.2 Injectable IVF Medications Segment by Type
1.2.1 Global Injectable IVF Medications Market Value Comparison by Type (2024-2030)
1.2.2 Follicle Stimulating Hormone (FSH)
1.2.3 Luteinizing Hormone (LH)
1.2.4 Human Chorionic Gonadotropin (hCG)
1.2.5 Others
1.3 Injectable IVF Medications Segment by Application
1.3.1 Global Injectable IVF Medications Market Value by Application: (2024-2030)
1.3.2 IVF and Embryo Transfer
1.3.3 Infertility Treatment
1.4 Global Injectable IVF Medications Market Size Estimates and Forecasts
1.4.1 Global Injectable IVF Medications Revenue 2019-2030
1.4.2 Global Injectable IVF Medications Sales 2019-2030
1.4.3 Global Injectable IVF Medications Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Injectable IVF Medications Market Competition by Manufacturers
2.1 Global Injectable IVF Medications Sales Market Share by Manufacturers (2019-2024)
2.2 Global Injectable IVF Medications Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Injectable IVF Medications Average Price by Manufacturers (2019-2024)
2.4 Global Injectable IVF Medications Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Injectable IVF Medications, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Injectable IVF Medications, Product Type & Application
2.7 Injectable IVF Medications Market Competitive Situation and Trends
2.7.1 Injectable IVF Medications Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Injectable IVF Medications Players Market Share by Revenue
2.7.3 Global Injectable IVF Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Injectable IVF Medications Retrospective Market Scenario by Region
3.1 Global Injectable IVF Medications Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Injectable IVF Medications Global Injectable IVF Medications Sales by Region: 2019-2030
3.2.1 Global Injectable IVF Medications Sales by Region: 2019-2024
3.2.2 Global Injectable IVF Medications Sales by Region: 2025-2030
3.3 Global Injectable IVF Medications Global Injectable IVF Medications Revenue by Region: 2019-2030
3.3.1 Global Injectable IVF Medications Revenue by Region: 2019-2024
3.3.2 Global Injectable IVF Medications Revenue by Region: 2025-2030
3.4 North America Injectable IVF Medications Market Facts & Figures by Country
3.4.1 North America Injectable IVF Medications Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Injectable IVF Medications Sales by Country (2019-2030)
3.4.3 North America Injectable IVF Medications Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Injectable IVF Medications Market Facts & Figures by Country
3.5.1 Europe Injectable IVF Medications Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Injectable IVF Medications Sales by Country (2019-2030)
3.5.3 Europe Injectable IVF Medications Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Injectable IVF Medications Market Facts & Figures by Country
3.6.1 Asia Pacific Injectable IVF Medications Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Injectable IVF Medications Sales by Country (2019-2030)
3.6.3 Asia Pacific Injectable IVF Medications Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Injectable IVF Medications Market Facts & Figures by Country
3.7.1 Latin America Injectable IVF Medications Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Injectable IVF Medications Sales by Country (2019-2030)
3.7.3 Latin America Injectable IVF Medications Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Injectable IVF Medications Market Facts & Figures by Country
3.8.1 Middle East and Africa Injectable IVF Medications Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Injectable IVF Medications Sales by Country (2019-2030)
3.8.3 Middle East and Africa Injectable IVF Medications Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Injectable IVF Medications Sales by Type (2019-2030)
4.1.1 Global Injectable IVF Medications Sales by Type (2019-2024)
4.1.2 Global Injectable IVF Medications Sales by Type (2025-2030)
4.1.3 Global Injectable IVF Medications Sales Market Share by Type (2019-2030)
4.2 Global Injectable IVF Medications Revenue by Type (2019-2030)
4.2.1 Global Injectable IVF Medications Revenue by Type (2019-2024)
4.2.2 Global Injectable IVF Medications Revenue by Type (2025-2030)
4.2.3 Global Injectable IVF Medications Revenue Market Share by Type (2019-2030)
4.3 Global Injectable IVF Medications Price by Type (2019-2030)
5 Segment by Application
5.1 Global Injectable IVF Medications Sales by Application (2019-2030)
5.1.1 Global Injectable IVF Medications Sales by Application (2019-2024)
5.1.2 Global Injectable IVF Medications Sales by Application (2025-2030)
5.1.3 Global Injectable IVF Medications Sales Market Share by Application (2019-2030)
5.2 Global Injectable IVF Medications Revenue by Application (2019-2030)
5.2.1 Global Injectable IVF Medications Revenue by Application (2019-2024)
5.2.2 Global Injectable IVF Medications Revenue by Application (2025-2030)
5.2.3 Global Injectable IVF Medications Revenue Market Share by Application (2019-2030)
5.3 Global Injectable IVF Medications Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Gonal-F (Merck)
6.1.1 Gonal-F (Merck) Corporation Information
6.1.2 Gonal-F (Merck) Description and Business Overview
6.1.3 Gonal-F (Merck) Injectable IVF Medications Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Gonal-F (Merck) Injectable IVF Medications Product Portfolio
6.1.5 Gonal-F (Merck) Recent Developments/Updates
6.2 Follistim (Organon)
6.2.1 Follistim (Organon) Corporation Information
6.2.2 Follistim (Organon) Description and Business Overview
6.2.3 Follistim (Organon) Injectable IVF Medications Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Follistim (Organon) Injectable IVF Medications Product Portfolio
6.2.5 Follistim (Organon) Recent Developments/Updates
6.3 Bravelle (Ferring)
6.3.1 Bravelle (Ferring) Corporation Information
6.3.2 Bravelle (Ferring) Description and Business Overview
6.3.3 Bravelle (Ferring) Injectable IVF Medications Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bravelle (Ferring) Injectable IVF Medications Product Portfolio
6.3.5 Bravelle (Ferring) Recent Developments/Updates
6.4 Menopur (Ferring)
6.4.1 Menopur (Ferring) Corporation Information
6.4.2 Menopur (Ferring) Description and Business Overview
6.4.3 Menopur (Ferring) Injectable IVF Medications Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Menopur (Ferring) Injectable IVF Medications Product Portfolio
6.4.5 Menopur (Ferring) Recent Developments/Updates
6.5 Fostimon (IBSA)
6.5.1 Fostimon (IBSA) Corporation Information
6.5.2 Fostimon (IBSA) Description and Business Overview
6.5.3 Fostimon (IBSA) Injectable IVF Medications Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Fostimon (IBSA) Injectable IVF Medications Product Portfolio
6.5.5 Fostimon (IBSA) Recent Developments/Updates
6.6 Puregon (Organon)
6.6.1 Puregon (Organon) Corporation Information
6.6.2 Puregon (Organon) Description and Business Overview
6.6.3 Puregon (Organon) Injectable IVF Medications Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Puregon (Organon) Injectable IVF Medications Product Portfolio
6.6.5 Puregon (Organon) Recent Developments/Updates
6.7 BEMFOLA (Gedeon Richter)
6.6.1 BEMFOLA (Gedeon Richter) Corporation Information
6.6.2 BEMFOLA (Gedeon Richter) Description and Business Overview
6.6.3 BEMFOLA (Gedeon Richter) Injectable IVF Medications Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BEMFOLA (Gedeon Richter) Injectable IVF Medications Product Portfolio
6.7.5 BEMFOLA (Gedeon Richter) Recent Developments/Updates
6.8 Novarel (Ferring)
6.8.1 Novarel (Ferring) Corporation Information
6.8.2 Novarel (Ferring) Description and Business Overview
6.8.3 Novarel (Ferring) Injectable IVF Medications Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Novarel (Ferring) Injectable IVF Medications Product Portfolio
6.8.5 Novarel (Ferring) Recent Developments/Updates
6.9 Ovidrel (Merck)
6.9.1 Ovidrel (Merck) Corporation Information
6.9.2 Ovidrel (Merck) Description and Business Overview
6.9.3 Ovidrel (Merck) Injectable IVF Medications Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Ovidrel (Merck) Injectable IVF Medications Product Portfolio
6.9.5 Ovidrel (Merck) Recent Developments/Updates
6.10 Synarel (Pfizer Medical)
6.10.1 Synarel (Pfizer Medical) Corporation Information
6.10.2 Synarel (Pfizer Medical) Description and Business Overview
6.10.3 Synarel (Pfizer Medical) Injectable IVF Medications Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Synarel (Pfizer Medical) Injectable IVF Medications Product Portfolio
6.10.5 Synarel (Pfizer Medical) Recent Developments/Updates
6.11 Follitrope (LG Chem)
6.11.1 Follitrope (LG Chem) Corporation Information
6.11.2 Follitrope (LG Chem) Injectable IVF Medications Description and Business Overview
6.11.3 Follitrope (LG Chem) Injectable IVF Medications Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Follitrope (LG Chem) Injectable IVF Medications Product Portfolio
6.11.5 Follitrope (LG Chem) Recent Developments/Updates
6.12 Profasi (Serum Institute Of India)
6.12.1 Profasi (Serum Institute Of India) Corporation Information
6.12.2 Profasi (Serum Institute Of India) Injectable IVF Medications Description and Business Overview
6.12.3 Profasi (Serum Institute Of India) Injectable IVF Medications Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Profasi (Serum Institute Of India) Injectable IVF Medications Product Portfolio
6.12.5 Profasi (Serum Institute Of India) Recent Developments/Updates
6.13 Livzon
6.13.1 Livzon Corporation Information
6.13.2 Livzon Injectable IVF Medications Description and Business Overview
6.13.3 Livzon Injectable IVF Medications Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Livzon Injectable IVF Medications Product Portfolio
6.13.5 Livzon Recent Developments/Updates
6.14 GenSci
6.14.1 GenSci Corporation Information
6.14.2 GenSci Injectable IVF Medications Description and Business Overview
6.14.3 GenSci Injectable IVF Medications Sales, Revenue and Gross Margin (2019-2024)
6.14.4 GenSci Injectable IVF Medications Product Portfolio
6.14.5 GenSci Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Injectable IVF Medications Industry Chain Analysis
7.2 Injectable IVF Medications Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Injectable IVF Medications Production Mode & Process
7.4 Injectable IVF Medications Sales and Marketing
7.4.1 Injectable IVF Medications Sales Channels
7.4.2 Injectable IVF Medications Distributors
7.5 Injectable IVF Medications Customers
8 Injectable IVF Medications Market Dynamics
8.1 Injectable IVF Medications Industry Trends
8.2 Injectable IVF Medications Market Drivers
8.3 Injectable IVF Medications Market Challenges
8.4 Injectable IVF Medications Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Injectable IVF Medications Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Injectable IVF Medications Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Injectable IVF Medications Market Competitive Situation by Manufacturers in 2023
Table 4. Global Injectable IVF Medications Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Injectable IVF Medications Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Injectable IVF Medications Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Injectable IVF Medications Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Injectable IVF Medications Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Injectable IVF Medications, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Injectable IVF Medications, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Injectable IVF Medications, Product Type & Application
Table 12. Global Key Manufacturers of Injectable IVF Medications, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Injectable IVF Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable IVF Medications as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Injectable IVF Medications Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Injectable IVF Medications Sales by Region (2019-2024) & (K Units)
Table 18. Global Injectable IVF Medications Sales Market Share by Region (2019-2024)
Table 19. Global Injectable IVF Medications Sales by Region (2025-2030) & (K Units)
Table 20. Global Injectable IVF Medications Sales Market Share by Region (2025-2030)
Table 21. Global Injectable IVF Medications Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Injectable IVF Medications Revenue Market Share by Region (2019-2024)
Table 23. Global Injectable IVF Medications Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Injectable IVF Medications Revenue Market Share by Region (2025-2030)
Table 25. North America Injectable IVF Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Injectable IVF Medications Sales by Country (2019-2024) & (K Units)
Table 27. North America Injectable IVF Medications Sales by Country (2025-2030) & (K Units)
Table 28. North America Injectable IVF Medications Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Injectable IVF Medications Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Injectable IVF Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Injectable IVF Medications Sales by Country (2019-2024) & (K Units)
Table 32. Europe Injectable IVF Medications Sales by Country (2025-2030) & (K Units)
Table 33. Europe Injectable IVF Medications Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Injectable IVF Medications Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Injectable IVF Medications Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Injectable IVF Medications Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Injectable IVF Medications Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Injectable IVF Medications Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Injectable IVF Medications Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Injectable IVF Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Injectable IVF Medications Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Injectable IVF Medications Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Injectable IVF Medications Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Injectable IVF Medications Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Injectable IVF Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Injectable IVF Medications Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Injectable IVF Medications Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Injectable IVF Medications Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Injectable IVF Medications Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Injectable IVF Medications Sales (K Units) by Type (2019-2024)
Table 51. Global Injectable IVF Medications Sales (K Units) by Type (2025-2030)
Table 52. Global Injectable IVF Medications Sales Market Share by Type (2019-2024)
Table 53. Global Injectable IVF Medications Sales Market Share by Type (2025-2030)
Table 54. Global Injectable IVF Medications Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Injectable IVF Medications Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Injectable IVF Medications Revenue Market Share by Type (2019-2024)
Table 57. Global Injectable IVF Medications Revenue Market Share by Type (2025-2030)
Table 58. Global Injectable IVF Medications Price (US$/Unit) by Type (2019-2024)
Table 59. Global Injectable IVF Medications Price (US$/Unit) by Type (2025-2030)
Table 60. Global Injectable IVF Medications Sales (K Units) by Application (2019-2024)
Table 61. Global Injectable IVF Medications Sales (K Units) by Application (2025-2030)
Table 62. Global Injectable IVF Medications Sales Market Share by Application (2019-2024)
Table 63. Global Injectable IVF Medications Sales Market Share by Application (2025-2030)
Table 64. Global Injectable IVF Medications Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Injectable IVF Medications Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Injectable IVF Medications Revenue Market Share by Application (2019-2024)
Table 67. Global Injectable IVF Medications Revenue Market Share by Application (2025-2030)
Table 68. Global Injectable IVF Medications Price (US$/Unit) by Application (2019-2024)
Table 69. Global Injectable IVF Medications Price (US$/Unit) by Application (2025-2030)
Table 70. Gonal-F (Merck) Corporation Information
Table 71. Gonal-F (Merck) Description and Business Overview
Table 72. Gonal-F (Merck) Injectable IVF Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Gonal-F (Merck) Injectable IVF Medications Product
Table 74. Gonal-F (Merck) Recent Developments/Updates
Table 75. Follistim (Organon) Corporation Information
Table 76. Follistim (Organon) Description and Business Overview
Table 77. Follistim (Organon) Injectable IVF Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Follistim (Organon) Injectable IVF Medications Product
Table 79. Follistim (Organon) Recent Developments/Updates
Table 80. Bravelle (Ferring) Corporation Information
Table 81. Bravelle (Ferring) Description and Business Overview
Table 82. Bravelle (Ferring) Injectable IVF Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Bravelle (Ferring) Injectable IVF Medications Product
Table 84. Bravelle (Ferring) Recent Developments/Updates
Table 85. Menopur (Ferring) Corporation Information
Table 86. Menopur (Ferring) Description and Business Overview
Table 87. Menopur (Ferring) Injectable IVF Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Menopur (Ferring) Injectable IVF Medications Product
Table 89. Menopur (Ferring) Recent Developments/Updates
Table 90. Fostimon (IBSA) Corporation Information
Table 91. Fostimon (IBSA) Description and Business Overview
Table 92. Fostimon (IBSA) Injectable IVF Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Fostimon (IBSA) Injectable IVF Medications Product
Table 94. Fostimon (IBSA) Recent Developments/Updates
Table 95. Puregon (Organon) Corporation Information
Table 96. Puregon (Organon) Description and Business Overview
Table 97. Puregon (Organon) Injectable IVF Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Puregon (Organon) Injectable IVF Medications Product
Table 99. Puregon (Organon) Recent Developments/Updates
Table 100. BEMFOLA (Gedeon Richter) Corporation Information
Table 101. BEMFOLA (Gedeon Richter) Description and Business Overview
Table 102. BEMFOLA (Gedeon Richter) Injectable IVF Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. BEMFOLA (Gedeon Richter) Injectable IVF Medications Product
Table 104. BEMFOLA (Gedeon Richter) Recent Developments/Updates
Table 105. Novarel (Ferring) Corporation Information
Table 106. Novarel (Ferring) Description and Business Overview
Table 107. Novarel (Ferring) Injectable IVF Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Novarel (Ferring) Injectable IVF Medications Product
Table 109. Novarel (Ferring) Recent Developments/Updates
Table 110. Ovidrel (Merck) Corporation Information
Table 111. Ovidrel (Merck) Description and Business Overview
Table 112. Ovidrel (Merck) Injectable IVF Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Ovidrel (Merck) Injectable IVF Medications Product
Table 114. Ovidrel (Merck) Recent Developments/Updates
Table 115. Synarel (Pfizer Medical) Corporation Information
Table 116. Synarel (Pfizer Medical) Description and Business Overview
Table 117. Synarel (Pfizer Medical) Injectable IVF Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Synarel (Pfizer Medical) Injectable IVF Medications Product
Table 119. Synarel (Pfizer Medical) Recent Developments/Updates
Table 120. Follitrope (LG Chem) Corporation Information
Table 121. Follitrope (LG Chem) Description and Business Overview
Table 122. Follitrope (LG Chem) Injectable IVF Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Follitrope (LG Chem) Injectable IVF Medications Product
Table 124. Follitrope (LG Chem) Recent Developments/Updates
Table 125. Profasi (Serum Institute Of India) Corporation Information
Table 126. Profasi (Serum Institute Of India) Description and Business Overview
Table 127. Profasi (Serum Institute Of India) Injectable IVF Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Profasi (Serum Institute Of India) Injectable IVF Medications Product
Table 129. Profasi (Serum Institute Of India) Recent Developments/Updates
Table 130. Livzon Corporation Information
Table 131. Livzon Description and Business Overview
Table 132. Livzon Injectable IVF Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Livzon Injectable IVF Medications Product
Table 134. Livzon Recent Developments/Updates
Table 135. GenSci Corporation Information
Table 136. GenSci Description and Business Overview
Table 137. GenSci Injectable IVF Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. GenSci Injectable IVF Medications Product
Table 139. GenSci Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Injectable IVF Medications Distributors List
Table 143. Injectable IVF Medications Customers List
Table 144. Injectable IVF Medications Market Trends
Table 145. Injectable IVF Medications Market Drivers
Table 146. Injectable IVF Medications Market Challenges
Table 147. Injectable IVF Medications Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Injectable IVF Medications
Figure 2. Global Injectable IVF Medications Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Injectable IVF Medications Market Share by Type in 2023 & 2030
Figure 4. Follicle Stimulating Hormone (FSH) Product Picture
Figure 5. Luteinizing Hormone (LH) Product Picture
Figure 6. Human Chorionic Gonadotropin (hCG) Product Picture
Figure 7. Others Product Picture
Figure 8. Global Injectable IVF Medications Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Injectable IVF Medications Market Share by Application in 2023 & 2030
Figure 10. IVF and Embryo Transfer
Figure 11. Infertility Treatment
Figure 12. Global Injectable IVF Medications Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Injectable IVF Medications Market Size (2019-2030) & (US$ Million)
Figure 14. Global Injectable IVF Medications Sales (2019-2030) & (K Units)
Figure 15. Global Injectable IVF Medications Average Price (US$/Unit) & (2019-2030)
Figure 16. Injectable IVF Medications Report Years Considered
Figure 17. Injectable IVF Medications Sales Share by Manufacturers in 2023
Figure 18. Global Injectable IVF Medications Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Injectable IVF Medications Players: Market Share by Revenue in 2023
Figure 20. Injectable IVF Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Injectable IVF Medications Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Injectable IVF Medications Sales Market Share by Country (2019-2030)
Figure 23. North America Injectable IVF Medications Revenue Market Share by Country (2019-2030)
Figure 24. United States Injectable IVF Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Injectable IVF Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Injectable IVF Medications Sales Market Share by Country (2019-2030)
Figure 27. Europe Injectable IVF Medications Revenue Market Share by Country (2019-2030)
Figure 28. Germany Injectable IVF Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Injectable IVF Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Injectable IVF Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Injectable IVF Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Netherlands Injectable IVF Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Injectable IVF Medications Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Injectable IVF Medications Revenue Market Share by Region (2019-2030)
Figure 35. China Injectable IVF Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Injectable IVF Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Injectable IVF Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Injectable IVF Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Injectable IVF Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Injectable IVF Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Injectable IVF Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Injectable IVF Medications Sales Market Share by Country (2019-2030)
Figure 43. Latin America Injectable IVF Medications Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Injectable IVF Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Injectable IVF Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Injectable IVF Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Colombia Injectable IVF Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Injectable IVF Medications Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Injectable IVF Medications Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Injectable IVF Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Injectable IVF Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Injectable IVF Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Injectable IVF Medications by Type (2019-2030)
Figure 54. Global Revenue Market Share of Injectable IVF Medications by Type (2019-2030)
Figure 55. Global Injectable IVF Medications Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Injectable IVF Medications by Application (2019-2030)
Figure 57. Global Revenue Market Share of Injectable IVF Medications by Application (2019-2030)
Figure 58. Global Injectable IVF Medications Price (US$/Unit) by Application (2019-2030)
Figure 59. Injectable IVF Medications Value Chain
Figure 60. Injectable IVF Medications Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
